Nomura Holdings’s AstraZeneca AZN Stock Holding History

Nomura Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,450	Closed	-$12.3M	–	1465
2025 Q1	$12.3M	Buy	+83,450	New	+$12.1M	0.02%	425
2015 Q1	–	Sell	-134,000	Closed	-$9.45M	–	1758
2014 Q4	$9.45M	Sell	134,000 -2,492,000	-95%	-$178M	0.03%	375
2014 Q3	$188M	Buy	2,626,000 +2,025,500	+337%	+$148M	0.51%	40
2014 Q2	$44.6M	Buy	600,500 +550,500	+1,101%	+$39.8M	0.01%	174
2014 Q1	$3.24M	Buy	+50,000	New	+$3.23M	﹤0.01%	931

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Nomura Holdings's AZN Position: Q1 2026 in Review

Nomura Holdings sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 54,898 shares — an estimated $10.1M sold.

Nomura Holdings first reported a position in AZN in Q3 2013 and held it in 21 quarters. The position peaked at $11.4M in Q1 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Nomura Holdings reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Nomura Holdings sold 54,898 AstraZeneca shares in Q1 2026, an estimated $10.1M.
Nomura Holdings first reported a position in AstraZeneca in Q3 2013 and held it in 21 quarters.
Nomura Holdings's AstraZeneca position peaked at $11.4M in Q1 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.